Malignant melanoma antigen expression increasing agent and use thereof

摘要

Disclosed is a means which is effective for the treatment of melanoma. Specifically disclosed is an agent for increasing the expression of a malignant melanoma antigen, which comprises a compound selected from the group consisting of methotrexate, paclitaxel, daunorubicin hydrochloride (daunorubicin, HCl), doxorubicin hydrochloride (doxorubicin, HCl), actinomycin D, camptothecin, etoposide, cytochalasin D, 3-ATA (3-amino-9-thio(10H)-acridone), aphidicolin, bisindolylmaleimide I, an arabino nucleoside (cytosine arabinoside), curcumin, 2',3'-dideoxythymidine triphosphate (2',3'-dideoxythymidine 5'-triphosphate), a thymidine dimer (dipyrimidine dithymidylic acid), pyridoxal phosphate (pyridoxal 5'-phosphate hydrate), epigallocatechin gallate ((-)-epigallocatechin gallate), vidarabine, resveratrol and lithocholic acid.